GuoLine Advisory’s Thermo Fisher Scientific TMO Stock Holding History

GuoLine Advisory’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$53.2M	Hold	78,800	–	–	4.58%	7
2026 Q2	$39.5M	Hold	78,800	–	–	3.68%	10
2026 Q1	$38.7M	Hold	78,800	–	–	4.05%	9
2025 Q4	$45.7M	Hold	78,800	–	–	4.2%	8
2025 Q3	$38.2M	Hold	78,800	–	–	3.81%	9
2025 Q2	$32M	Hold	78,800	–	–	3.39%	15
2025 Q1	$39.2M	Sell	78,800 -11,200	-12%	-$6.07M	4.15%	9
2024 Q4	$46.8M	Hold	90,000	–	–	4.83%	7
2024 Q3	$55.7M	Hold	90,000	–	–	5.67%	5
2024 Q2	$49.8M	Hold	90,000	–	–	5.31%	5
2024 Q1	$52.3M	Hold	90,000	–	–	6.38%	5
2023 Q4	$47.8M	Hold	90,000	–	–	7.56%	5
2023 Q3	$45.6M	Hold	90,000	–	–	8.99%	4
2023 Q2	$47M	Hold	90,000	–	–	9.26%	5
2023 Q1	$51.9M	Buy	+90,000	New	+$50.7M	14.58%	3

Other funds holding TMO

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.36B AUM 0.68% 1-Year Est. Return

GuoLine Advisory's TMO Position: Q3 2026 in Review

GuoLine Advisory held its Thermo Fisher Scientific (TMO) position steady in Q3 2026 at 78,800 shares worth $53.2M. The position accounts for 4.58% of the portfolio, ranked #7.

GuoLine Advisory first reported a position in TMO in Q1 2023 and has held it in 15 quarters since. The position peaked at $55.7M in Q3 2024. 1,189 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

GuoLine Advisory held 78,800 shares of Thermo Fisher Scientific worth $53.2M as of Q3 2026.
GuoLine Advisory left its Thermo Fisher Scientific share count unchanged in Q3 2026.
Thermo Fisher Scientific made up 4.58% of GuoLine Advisory's portfolio in Q3 2026, its #7 holding.
GuoLine Advisory first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 15 quarters since.
GuoLine Advisory's Thermo Fisher Scientific position peaked at $55.7M in Q3 2024.
1,189 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on GuoLine Advisory's 13F filing for Q3 2026, filed 6 Oct 2026.